New compounds may aid in development of targeted therapies for a rare pediatric cancer
(Van Andel Research Institute) Two recently discovered compounds have shown promise in preclinical studies for treating Ewing sarcoma, a rare cancer that predominantly affects children and adolescents.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Bone Cancers | Cancer | Cancer & Oncology | Cancer in Adolescents | Child Development | Children | Ewing's Sarcoma | Pediatrics | Sarcomas | Study